United Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts that cover United Therapeutics stock have a consensus rating of "Buy" and an average price target of $520, which forecasts a 4.28% increase in the stock price over the next year. The lowest target is $330 and the highest is $645.

Price Target: $520 (+4.28%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$330	$520	$525	$645
Change	-33.82%	+4.28%	+5.28%	+29.35%

Analyst Ratings

The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	6	6	4	4	4	5
Buy	5	5	4	4	4	4
Hold	4	5	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	12	12	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $525 → $600	Strong Buy	Maintains	$525 → $600	+20.32%	Feb 26, 2026
Joseph Thome TD Cowen	TD Cowen	Strong Buy Maintains $525 → $575	Strong Buy	Maintains	$525 → $575	+15.31%	Feb 26, 2026
Andreas Argyrides Oppenheimer	Oppenheimer	Buy Maintains $575 → $600	Buy	Maintains	$575 → $600	+20.32%	Feb 26, 2026
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $587 → $643	Buy	Maintains	$587 → $643	+28.95%	Feb 26, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Hold Maintains $423 → $466	Hold	Maintains	$423 → $466	-6.55%	Feb 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.46B

from 3.18B

8.56%

from 3.18B

Revenue Next Year

3.83B

from 3.46B

10.71%

from 3.46B

EPS This Year

29.47

from 27.86

5.78%

from 27.86

EPS Next Year

31.83

from 29.47

8.02%

from 29.47

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.69B	1.94B	2.33B	2.88B	3.18B	3.46B	3.83B
Revenue Growth	13.63%	14.88%	20.20%	23.63%	10.61%	8.56%	10.71%
EPS	10.06	15.00	19.81	24.64	27.86	29.47	31.83
EPS Growth	-12.83%	49.11%	32.07%	24.38%	13.07%	5.78%	8.02%
Forward PE	-	-	-	-	-	16.92	15.67
No. Analysts	-	-	-	-	-	18	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	3.7B	4.5B
Avg	3.5B	3.8B
Low	3.0B	3.1B

Revenue Growth

Revenue Growth	2026	2027
High	16.5%	30.5%
Avg	8.6%	10.7%
Low	-4.7%	-9.5%

EPS Forecast

EPS	2026	2027
High	34.06	39.43
Avg	29.47	31.83
Low	25.17	21.63

EPS Growth

EPS Growth	2026	2027
High	22.3%	33.8%
Avg	5.8%	8.0%
Low	-9.7%	-26.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.